Palvella Therapeutics, Inc.(PVLA US)
$162.28+9.356.11%
- Pricing and plans
Get the full experience
We save the real magic for signed-in users.
Get the full experience
We save the real magic for signed-in users.
Get the full experience
We save the real magic for signed-in users.
| Millions USD (ex. Per Share) | FY202012/31/2020 | FY202112/31/2021 | FY202212/31/2022 | FY202312/31/2023 | FY202412/31/2024 | FY202512/31/2025 | Last 12M03/31/2026 | ||
|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | 7.4 | 83.6 | 58.0 | 206.4 | |||||
| Short Term Investments | - | - | - | 55.5 | |||||
| Cash and Short Term Investments | 7.4 | 83.6 | 58.0 | 261.9 | |||||
| Net Receivables | - | 2.3 | - | - | |||||
| Inventory | - | - | - | - | |||||
| Other Current Assets | 0.2 | 2.3 | 1.0 | 1.4 | |||||
| Total Current Assets | 7.5 | 88.2 | 59.0 | 263.2 | |||||
| Property, Plant & Equipment | - | - | 0.6 | 0.5 | |||||
| Long Term Investments | - | - | - | - | |||||
| Other Non-Current Assets | - | - | - | - | |||||
| Total Non-Current Assets | - | - | 0.6 | 0.5 | |||||
| Total Assets | 7.5 | 88.2 | 59.6 | 263.8 | |||||
| Account Payables | 0.9 | 4.6 | 4.6 | 5.4 | |||||
| Short Term Debt | - | - | - | - | |||||
| Deferred Revenue | - | - | - | - | |||||
| Other Current Liabilities | 0.3 | 6.2 | 4.8 | 1.6 | |||||
| Total Current Liabilities | 2.4 | 12.0 | 11.3 | 9.1 | |||||
| Long Term Debt | - | - | 0.4 | 0.4 | |||||
| Other Non-Current Liabilities | 9.1 | 13.6 | 19.8 | 22.0 | |||||
| Total Non-Current Liabilities | 9.1 | 13.6 | 20.2 | 22.3 | |||||
| Total Liabilities | 11.4 | 25.6 | 31.6 | 31.4 | |||||
| Common Stock | - | 0.0 | 0.0 | 0.0 | |||||
| Retained Earnings | -76.3 | -93.7 | -135.5 | -151.2 | |||||
| Total Stockholders Equity | -3.9 | 62.6 | 28.0 | 232.3 | |||||
| Total Liabilities and Equity | 7.5 | 88.2 | 59.6 | 263.8 | |||||
| Millions USD (ex. Per Share) | FY202012/31/2020 | FY202112/31/2021 | FY202212/31/2022 | FY202312/31/2023 | FY202412/31/2024 | FY202512/31/2025 | Last 12M03/31/2026 | ||
|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | 7.4 | 83.6 | 58.0 | 206.4 | |||||
| Short Term Investments | - | - | - | 55.5 | |||||
| Cash and Short Term Investments | 7.4 | 83.6 | 58.0 | 261.9 | |||||
| Net Receivables | - | 2.3 | - | - | |||||
| Inventory | - | - | - | - | |||||
| Other Current Assets | 0.2 | 2.3 | 1.0 | 1.4 | |||||
| Total Current Assets | 7.5 | 88.2 | 59.0 | 263.2 | |||||
| Property, Plant & Equipment | - | - | 0.6 | 0.5 | |||||
| Long Term Investments | - | - | - | - | |||||
| Other Non-Current Assets | - | - | - | - | |||||
| Total Non-Current Assets | - | - | 0.6 | 0.5 | |||||
| Total Assets | 7.5 | 88.2 | 59.6 | 263.8 | |||||
| Account Payables | 0.9 | 4.6 | 4.6 | 5.4 | |||||
| Short Term Debt | - | - | - | - | |||||
| Deferred Revenue | - | - | - | - | |||||
| Other Current Liabilities | 0.3 | 6.2 | 4.8 | 1.6 | |||||
| Total Current Liabilities | 2.4 | 12.0 | 11.3 | 9.1 | |||||
| Long Term Debt | - | - | 0.4 | 0.4 | |||||
| Other Non-Current Liabilities | 9.1 | 13.6 | 19.8 | 22.0 | |||||
| Total Non-Current Liabilities | 9.1 | 13.6 | 20.2 | 22.3 | |||||
| Total Liabilities | 11.4 | 25.6 | 31.6 | 31.4 | |||||
| Common Stock | - | 0.0 | 0.0 | 0.0 | |||||
| Retained Earnings | -76.3 | -93.7 | -135.5 | -151.2 | |||||
| Total Stockholders Equity | -3.9 | 62.6 | 28.0 | 232.3 | |||||
| Total Liabilities and Equity | 7.5 | 88.2 | 59.6 | 263.8 | |||||